Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog

Veterinary and Comparative Oncology

Volumn 10, Issue 4, 2012, Pages 312-318

  Valentini, F ^a   Tasca, S ^b   Gavazza, A ^a   Lubas, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b San Marco Private Veterinary Laboratory   (Italy)

Author keywords

Clinical pathology; Comparative oncology; Immunology; Oncology; Small animal internal medicine

Indexed keywords

BETA3 INTEGRIN; CD9 ANTIGEN; MEMBRANE ANTIGEN; TUMOR MARKER;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DOG; DOG DISEASE; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM; METHODOLOGY;

ANIMALS; ANTIGENS, CD9; ANTIGENS, SURFACE; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; INTEGRIN BETA3; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 84868544757     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2011.00290.x     Document Type: Article

References (27)

1. Imamura N, Mtasiwa DM, Ota H, Inada T and Kuramoto A. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines. American Journal of Hematology 1990; 35: 65-67.
2. Yatomi Y, Yoneyama A and Nakahara K. Usefulness of CD9 detection in the diagnosis of acute megakaryoblastic leukemia. European Journal of Haematology 2004; 72: 229-230.
3. Matsuo Y, Drexler HG, Kaneda K, Kojima K, Ohtsuki Y, Hara M, Yasukawa M, Tanimoto M and Orita K. Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. Leukemia Research 2003; 27: 165-171.
4. Schuberth HJ, Kucinskiene G, Chu RM and Faldyna M. Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes. Veterinary Immunology and Immunopathology 2007; 119: 47-55.
5. Tasca S, Carli E, Caldin M, Menegazzo L, Furlanello T and Gallego LS. Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006). Veterinary Clinical Pathology 2008; 38: 2-12.
6. Ameri M, Wilkerson MJ, Stockham SL, Almes KM, Patton KM and Jackson T. Acute megakaryoblastic leukemia in German shepherd dog. Veterinary Clinical Pathology 2010; 39: 39-45.
7. Adam F, Villiers E, Watson S, Coyne K and Blackwood L. Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukemia. Veterinary and Comparative Oncology 2009; 7: 181-195.
8. Willmann M, Müllauer L, Schwendenwein I, Wolfesberger B, Kleiter M, Pagitz M, Hadzijusufovic E, Shibly S, Reifinger M, Thalhammer JG and Valent P. Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature. In Vivo 2009; 23: 911-918
9. Hamilton TA, Morrison WB and DeNicola DB. Cytosine arabinoside chemotherapy for acute megakaryocytic leukemia in a cat. Journal of the American Veterinary Medical Association 1991; 199: 359-361
10. Park HM, Doster AR, Tashbaeva RE, Lee YM, Lyoo YS, Lee SJ, Kim HJ and Sur JH. Clinical, histological and immunohistochemical findings in a case of megakaryoblastic leukemia in a dog. Journal of Veterinary Diagnostic Investigation 2006; 18: 287-291.
11. Von Boros J and Korenyl A. Uber einem Fall von akuten Megakaryoblasten leukamie, zugleich einige Bemerkungen zum Problem der akuten Lukamie. Zeitschrift fur klinische Medizin 1931; 118: 679-718.
12. Messick J, Carothers M and Wellman M. Identification and characterization of megakaryoblasts in acute megakaryoblastic leukemia in a dog. Veterinary Pathology 1990; 27: 212-214.
13. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Annals of internal medicine 1985; 103: 460.
14. Gassmann W and Löffler H. Acute megakaryoblastic leukemia. Leukemia and Lymphoma 1995; 18: 69-73.
15. Burton S, Miller L, Horney B, Marks C and Shaw D. Acute megakaryoblastic leukemia in a cat. Veterinary Clinical Pathology 1996; 25: 6-9.
16. Rudolph R and Hubner C. Megakaryozyten leukose beim hund [Megakaryocytic leukosis in a dog]. Kleintier Praxis 1972; 17: 9-13.
17. Cain GR, Feldman BF, Kawakami TG and Jain NC. Platelet dysplasia associated with megakaryoblastic leukemia in a dog. Journal of the American Veterinary Medical Association 1986; 188: 529-530.
18. Cain GR, Kawakami TG and Jain NC. Radiation-induced megakaryoblastic leukemia in a dog. Veterinary Pathology 1985; 22: 641-643.
19. Suter SE, Vernau W, Fry MM and London CA. CD34+, CD41+ acute megakaryoblastic leukemia in a dog. Veterinary Clinical Pathology 2007; 36: 288-292.
20. Grindem CB. Blood cell markers. Veterinary Clinic of North America: Small Animal Practice 1996; 26: 1043-1064.
21. Ledieu D, Palazzi X, Marchal T and Fournel-Fleury C. Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog. Veterinary Clinical Pathology 2005; 34: 52-56.
22. Pucheu-Haston CM, Camus A, Taboada J, Gaunt SD, Snider TG and Lopez MK. Megakaryoblastic leukemia in a dog. Journal of the American Veterinary Medical Association 1995; 207: 194-196.
23. Jain NC, Blue ST and Grindem CB. Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Veterinary Clinical Pathology 1991; 20: 63-82.
24. Bennett JM, Catovsky D and Daniel MJ. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative group. Annals of Internal Medicine 1985; 103: 620-625.
25. Comazzi S, Gelain ME, Bonfanti U and Roccabianca P. Acute megakaryoblastic leukemia in dogs: a report of three cases and review of the literature. Journal of the American Animal Hospital Association 2010; 46: 327-335.
26. Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J and Uzan G. Molecular cloning of the CD9 antigen. A new family of cell surface proteins. Journal of Biological Chemistry 1991; 266: 117-122.
27. Reimann N, Bartnitzke S, Bullerdick J, Mischke R and Nolte I. Trisomy 1 in a canine acute leukemia indicating the pathogenetic importance of polysomy 1 in leukemias in dog. Cancer Genetic and Cytogenetic 1998; 101: 49-52.